Truvada: TDF/FTC daily
Descovy: TAF/FTC daily (not for vaginal exposure)
Cabotegravir: IM q2 months
Lenacapavir: SubQ q6 months (NEW 2024!)
Women: 500 mg PO BID × 7 days
Men: 2 g PO × 1 dose
Alternative: Tinidazole 2 g PO × 1
Tenofovir: 300 mg PO daily
Entecavir: 0.5-1 mg PO daily
PegIFN-α: 180 mcg SubQ weekly × 48 weeks
Sofosbuvir/Velpatasvir: 8-12 weeks
Glecaprevir/Pibrentasvir: 8-16 weeks
Ledipasvir/Sofosbuvir: 8-12 weeks